Latest Breaking News On - Phil dormitzer - Page 1 : comparemela.com

FDA approves first RSV vaccine for at-risk adults in their 50s

The RSV vaccine by GSK was previously approved only for adults 60 and older.

FDA approves GSK RSV vaccine for adults 50 to 59

The FDA's expanded approval could help GSK maintain its dominance in the RSV market, which includes shots from Pfizer and Moderna.

FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach

Recombinant Zoster Vaccine Demonstrates High Protection Against Shingles in Adult Patients

The recombinant zoster vaccine demonstrated a 79.7% efficacy in patients aged 50 years and older cumulatively within the 6- to 11-year period after vaccination.

GSK's shingles vaccine shown to maintain high protection in long-term study